The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway

This publication has 20 references indexed in Scilit:

• Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction
  European Respiratory Journal, 2008
• Cells, mediators and Toll-like receptors in COPD
  European Journal of Pharmacology, 2008
• LPS‐Induced Occult Loss in Mice Requires FGL2
  American Journal of Reproductive Immunology, 2007
• Expression of prothrombinase/fibroleukin gene fg12 in lung impairment in a murine severe acute respiratory syndrome model
  Virologica Sinica, 2007
• Cytokine-Induced Hepatic Apoptosis Is Dependent on FGL2/Fibroleukin: The Role of Sp1/Sp3 and STAT1/PU.1 Composite cis Elements
  The Journal of Immunology, 2006
• Role of Fibrinogen-Like Protein 2 Prothrombinase/Fibroleukin in Experimental and Human Allograft Rejection
  The Journal of Immunology, 2005
• Fibrinogen-like protein 2 fibroleukin expression and its correlation with disease progression in murine hepatitis virus type 3-induced fulminant hepatitis and in patients with severe viral hepatitis B
  World Journal of Gastroenterology, 2005
• Alveolar Macrophages as Orchestrators of COPD
  COPD: Journal of Chronic Obstructive Pulmonary Disease, 2004
• Soluble Fibrinogen-Like Protein 2/Fibroleukin Exhibits Immunosuppressive Properties: Suppressing T Cell Proliferation and Inhibiting Maturation of Bone Marrow-Derived Dendritic Cells
  The Journal of Immunology, 2003
• Kinetic Analysis of a Unique Direct Prothrombinase, fgl2 , and Identification of a Serine Residue Critical for the Prothrombinase Activity
  The Journal of Immunology, 2002